Kyverna Therapeutics, Inc. (KYTX)
(Delayed Data from NSDQ)
$15.42 USD
+0.17 (1.11%)
Updated May 17, 2024 04:00 PM ET
After-Market: $15.38 -0.04 (-0.26%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.74 |
EPS Last Quarter | -1.12 |
Last EPS Surprise | -27.27% |
ABR | 1.00 |
Earnings ESP
|
-0.45% |
---|---|
Current Year | -3.34 |
Next Year | -4.11 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
Low Estimate | 3.75M | 3.75M | 15.00M | 20.00M |
Year ago Sales | NA | NA | 7.03M | 15.00M |
Year over Year Growth Est. | NA | NA | 113.52% | 33.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.74 | -0.82 | -3.34 | -4.11 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.69 | -0.83 | -3.51 | -4.45 |
High Estimate | -0.69 | -0.81 | -3.11 | -3.50 |
Low Estimate | -0.79 | -0.83 | -3.51 | -4.45 |
Year ago EPS | NA | NA | -89.61 | -3.34 |
Year over Year Growth Est. | NA | NA | 96.27% | -23.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 2 | 2 | 2 | 1 |
Down Last 30 Days | 2 | 2 | 2 | 1 |
Down Last 60 Days | 1 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.74 | -0.82 | -3.34 | -4.11 |
7 Days Ago | -0.71 | -0.80 | -3.26 | -4.07 |
30 Days Ago | -0.71 | -0.80 | -3.26 | -4.07 |
60 Days Ago | -0.72 | -0.80 | -3.16 | -4.07 |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.74 | -0.82 | -3.45 | -4.42 |
Zacks Consensus Estimate | -0.74 | -0.82 | -3.34 | -4.11 |
Earnings ESP | -0.45% | 0.00% | -3.40% | -7.46% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.12 | NA | NA | NA | NA |
Estimate | -0.88 | NA | NA | NA | NA |
Difference | -0.24 | NA | NA | NA | -0.24 |
Surprise | -27.27% | NA | NA | NA | -27.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more